Literature DB >> 21763219

Metabolomics study of alcohol-induced liver injury and hepatocellular carcinoma xenografts in mice.

Shangfu Li1, Hongxia Liu, Yibao Jin, Shuhai Lin, Zongwei Cai, Yuyang Jiang.   

Abstract

Alcohol abuse is one of the major causes of liver injury and a promoter for hepatocellular carcinoma (HCC). To understand the disease-associated metabolic changes, we investigated and compared the profiles of metabolites in nude mice with alcohol-induced liver injury or bearing a HCC xenograft (HCCX). Alcohol-induced liver injury was achieved by daily administration of grain liquor, and HCC xenografts were generated by subcutaneous inoculation of HepG2 cells in nude mice. Metabolites in serum samples were profiled by ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC/Q-TOF MS). The acquired data was analyzed by principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA) to identify potential disease-specific biomarkers. Results showed that the phosphatidylcholine (PC) levels were significantly higher in both liver injury and HCCX mice compared with the control. Interestingly, lysophosphatidylcholines (LPCs) that contain saturated or monounsaturated fatty acids were reduced in both liver injury and HCCX mice, but polyunsaturated fatty acids LPCs were elevated in liver injury mice only. These data delineated the disease-related metabolic alterations of LPCs in liver injury and HCC, suggesting that the LPC profile in serum may be biomarkers for these two common liver diseases.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763219     DOI: 10.1016/j.jchromb.2011.06.018

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  25 in total

1.  Metabolomics study of type 2 diabetes using ultra-performance LC-ESI/quadrupole-TOF high-definition MS coupled with pattern recognition methods.

Authors:  Ai-hua Zhang; Hui Sun; Guang-li Yan; Ye Yuan; Ying Han; Xi-jun Wang
Journal:  J Physiol Biochem       Date:  2013-08-24       Impact factor: 4.158

2.  Potential serum biomarkers from a metabolomics study of autism.

Authors:  Han Wang; Shuang Liang; Maoqing Wang; Jingquan Gao; Caihong Sun; Jia Wang; Wei Xia; Shiying Wu; Susan J Sumner; Fengyu Zhang; Changhao Sun; Lijie Wu
Journal:  J Psychiatry Neurosci       Date:  2016-01       Impact factor: 6.186

3.  Targeted metabolic profiling of hepatocellular carcinoma and hepatitis C using LC-MS/MS.

Authors:  Hamid Baniasadi; G A Nagana Gowda; Haiwei Gu; Ao Zeng; Shui Zhuang; Nicholas Skill; Mary Maluccio; Daniel Raftery
Journal:  Electrophoresis       Date:  2013-09-01       Impact factor: 3.535

Review 4.  The metabolomic window into hepatobiliary disease.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  J Hepatol       Date:  2013-05-25       Impact factor: 25.083

5.  Chronic ethanol consumption alters mammalian gastrointestinal content metabolites.

Authors:  Guoxiang Xie; Wei Zhong; Xiaojiao Zheng; Qiong Li; Yunping Qiu; Houkai Li; Huiyuan Chen; Zhanxiang Zhou; Wei Jia
Journal:  J Proteome Res       Date:  2013-06-14       Impact factor: 4.466

6.  Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification.

Authors:  Diren Beyoğlu; Sandrine Imbeaud; Olivier Maurhofer; Paulette Bioulac-Sage; Jessica Zucman-Rossi; Jean-François Dufour; Jeffrey R Idle
Journal:  Hepatology       Date:  2013-05-08       Impact factor: 17.425

7.  Metabolomics reveals that tumor xenografts induce liver dysfunction.

Authors:  Fei Li; Andrew D Patterson; Kristopher W Krausz; Changtao Jiang; Huichang Bi; Anastasia L Sowers; John A Cook; James B Mitchell; Frank J Gonzalez
Journal:  Mol Cell Proteomics       Date:  2013-05-01       Impact factor: 5.911

8.  Metabolomics reveals trichloroacetate as a major contributor to trichloroethylene-induced metabolic alterations in mouse urine and serum.

Authors:  Zhong-Ze Fang; Kristopher W Krausz; Naoki Tanaka; Fei Li; Aijuan Qu; Jeffrey R Idle; Frank J Gonzalez
Journal:  Arch Toxicol       Date:  2013-04-11       Impact factor: 5.153

9.  Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.

Authors:  Asem I Fitian; David R Nelson; Chen Liu; Yiling Xu; Miguel Ararat; Roniel Cabrera
Journal:  Liver Int       Date:  2014-04-28       Impact factor: 5.828

10.  Detection of hepatocellular carcinoma in hepatitis C patients: biomarker discovery by LC-MS.

Authors:  Jeremiah Bowers; Emma Hughes; Nicholas Skill; Mary Maluccio; Daniel Raftery
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-03-02       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.